Spinchip Diagnostics AS

Representing the future of point-of-care testing, SpinChip® Diagnostics was founded in Norway in 2012. SpinChip®'s proprietary platform is focused on in-vitro diagnostics (IVD) to develop diagnostic tests for acute and chronic cardiac indications where test results are rapidly needed to provide patients with life-saving treatments. The platform is based on microfluidic technology in combination with nanotechnology-based cartridge assays, which together can relay test results as accurately as high-sensitive laboratory diagnostic machine within minutes, with only one drop of blood.